Mode
Text Size
Log in / Sign up

Pulsed-field ablation shows shorter ablation times and lower phrenic nerve palsy than cryoballoon ablationPulsed-field Ablation Shows Faster Times for Atrial Fibrillation Treatment

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that PFA is associated with shorter ablation times and lower phrenic nerve palsy rates than cryoballoon ablation.

This meta-analysis evaluates the efficacy and safety of pulsed-field ablation (PFA) using a pentaspline catheter compared to cryoballoon ablation (CBA) for pulmonary vein isolation in patients with atrial fibrillation. The analysis included a total of 2024 patients.

Key findings indicate that PFA is associated with significantly shorter ablation times (MD = -14.12; 95% CI: -16.31 to -11.93) and shorter left atrial dwell times (MD = -9.44; 95% CI: -15.69 to -3.19) compared to CBA. Regarding safety, PFA was associated with higher hypersensitive troponin release (MD = 547.29; 95% CI: 53.55 to 1041.03), while CBA was associated with a higher incidence of phrenic nerve palsy (OR = 0.06; 95% CI: 0.01 to 0.30). For atrial tachyarrhythmia recurrence, no significant difference was found (OR = 0.71; 95% CI: 0.48 to 1.06), though a lower incidence was noted specifically in patients with paroxysmal AF (OR = 0.62; 95% CI: 0.46 to 0.85).

Clinical implications suggest PFA may offer procedural advantages in terms of speed and specific safety profiles regarding phrenic nerve involvement. However, the lack of reported follow-up durations and specific study limitations in the data necessitates a cautious interpretation of long-term outcomes.

How this fits prior evidence

This meta-analysis addresses a gap in comparing specific ablation modalities for pulmonary vein isolation. While prior coverage established that clinical risk factors like smoking and sleep apnea increase arrhythmia recurrence after atrial fibrillation ablation, this study focuses on the technical and procedural differences between PFA and CBA. It provides specific data on ablation times and phrenic nerve palsy risks that were not addressed in previous coverage of atrial fibrillation management.

Researchers analyzed data from 2,024 patients with atrial fibrillation who underwent pulmonary vein isolation. The study compared a newer method called pulsed-field ablation (PFA) against the traditional cryoballoon ablation (CBA) technique.

The results showed that the PFA method was faster, with significantly shorter ablation and left atrial dwell times. While both methods were effective at treating the heart rhythm, the PFA group showed a lower incidence of certain heart rhythm issues in patients with paroxysmal atrial fibrillation.

Safety results showed different risks for each method. The PFA group had higher levels of troponin release, which is a marker of heart stress. However, the traditional cryoballoon method was linked to a higher incidence of phrenic nerve palsy. Because this is a meta-analysis of existing data, the results should be viewed as an overview of current evidence rather than a new clinical trial.

What this means for you:
Pulsed-field ablation may offer faster procedure times and lower nerve damage risks than cryoballoon ablation.

Common questions

How does pulsed-field ablation compare to cryoballoon ablation?

The study found that pulsed-field ablation (PFA) resulted in significantly shorter ablation times and shorter left atrial dwell times compared to cryoballoon ablation (CBA). While both methods were used to treat atrial fibrillation, PFA showed a lower incidence of certain heart rhythm issues in patients with paroxysmal atrial fibrillation.

Are there different safety risks for these two procedures?

Yes, the two methods showed different safety profiles. The pulsed-field ablation group showed higher hypersensitive troponin release. In contrast, the cryoballoon ablation group showed a higher incidence of phrenic nerve palsy. You should discuss these specific risks with your doctor to understand which approach is best for your situation.

Is pulsed-field ablation faster than traditional methods?

Yes, the data indicates that pulsed-field ablation is faster. The study reported a mean difference of -14.12 in ablation time and -9.44 in left atrial dwell time, meaning the PFA procedure took less time than the cryoballoon method.

Study Details

Study typeMeta analysis
Sample sizen = 2,024
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
BACKGROUND: Pulsed-field ablation (PFA) is an emerging technology for atrial fibrillation (AF) ablation. However, there is few studies comparing the clinical advantages and disadvantages of PFA and cryoballoon ablation (CBA). This study aimed to perform a comprehensive meta-analysis to evaluate the efficacy and safety of PFA using a pentaspline ablation catheter compared with CBA for treating AF. METHODS: This study was registered in the International Prospective Register of Systematic Reviews (ID: CRD420251061599). Studies comparing PFA using a pentaspline ablation catheter with CBA for pulmonary vein isolation (PVI) were systematically searched from database inception to March 2025. RESULTS: Six trials involving 2024 patients were included. No significant difference was observed in atrial tachyarrhythmia recurrence between PFA and CBA (OR) = 0.71; 95% confidence interval (CI): 0.48 to 1.06). However, in patients with paroxysmal AF, the PFA group exhibited a lower incidence of AT recurrence (OR = 0.62; 95% CI: 0.46 to 0.85). PFA was superior to CBA in terms of ablation time (MD) = -14.12; 95% CI: -16.31 to -11.93) and left atrial dwell time (MD = -9.44; 95% CI: -15.69 to -3.19). Hypersensitive troponin release was higher in the PFA group (MD = 547.29; 95% CI: 53.55 to 1041.03), while CBA was associated with a higher incidence of phrenic nerve palsy (OR = 0.06; 95% CI: 0.01 to 0.30). CONCLUSION: PFA demonstrates superior safety and efficacy compared with CBA for PVI in patients with AF. These findings provide additional procedural options for patients and electrophysiologists in clinical practice.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.